| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2006PNAS..103.5923E |
| P356 | DOI | 10.1073/PNAS.0601231103 |
| P932 | PMC publication ID | 1458674 |
| P698 | PubMed publication ID | 16585533 |
| P5875 | ResearchGate publication ID | 7193675 |
| P50 | author | Or zuk | Q113195424 |
| Eytan Domany | Q113195905 | ||
| P2093 | author name string | Liat Ein-Dor | |
| P2860 | cites work | Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt | Q24810271 |
| The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma | Q27824784 | ||
| Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 | ||
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| A theory of the learnable | Q29398622 | ||
| A molecular signature of metastasis in primary solid tumors | Q29614442 | ||
| Gene-expression profiles predict survival of patients with lung adenocarcinoma | Q29614443 | ||
| Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer | Q29615523 | ||
| Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses | Q29616071 | ||
| Breast cancer metastasis: markers and models | Q29618061 | ||
| Predicting the clinical status of human breast cancer by using gene expression profiles | Q33944626 | ||
| Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks | Q34130347 | ||
| Molecular classification and molecular forecasting of breast cancer: ready for clinical application? | Q36250255 | ||
| Genomics in breast cancer-therapeutic implications | Q36303896 | ||
| Outcome signature genes in breast cancer: is there a unique set? | Q42633433 | ||
| Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection | Q52107732 | ||
| FREQUENCY DISTRIBUTION OF THE VALUES OF THE CORRELATION COEFFIENTS IN SAMPLES FROM AN INDEFINITELY LARGE POPU;ATION | Q56657056 | ||
| Prediction of cancer outcome with microarrays: a multiple random validation strategy | Q62785637 | ||
| Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group | Q77347398 | ||
| Microarrays and molecular research: noise discovery? | Q81390417 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 5923-5928 | |
| P577 | publication date | 2006-04-03 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer | |
| P478 | volume | 103 |
| Q64062301 | A Comprehensive Survey of Tools and Software for Active Subnetwork Identification |
| Q34345157 | A Cross-Platform Comparison of Genome-Wide Expression Changes of Laser Microdissected Lung Tissue of C-Raf Transgenic Mice Using 3′IVT and Exon Array |
| Q64075026 | A Multi-Cohort and Multi-Omics Meta-Analysis Framework to Identify Network-Based Gene Signatures |
| Q92652655 | A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer |
| Q35584849 | A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft. |
| Q57837744 | A comparison of mechanistic signaling pathway activity analysis methods |
| Q37131390 | A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer |
| Q35630217 | A consensus prognostic gene expression classifier for ER positive breast cancer |
| Q93086744 | A core collection of pan-schizophrenia genes allows building cohort-specific signatures of affected brain |
| Q64256232 | A data-driven interactome of synergistic genes improves network-based cancer outcome prediction |
| Q44003623 | A frequency-based gene selection method to identify robust biomarkers for radiation dose prediction |
| Q33316224 | A gene sets approach for identifying prognostic gene signatures for outcome prediction |
| Q42607091 | A method for the detection of meaningful and reproducible group signatures from gene expression profiles |
| Q33279912 | A mixture model approach to the tests of concordance and discordance between two large-scale experiments with two-sample groups |
| Q27303204 | A mouse stromal response to tumor invasion predicts prostate and breast cancer patient survival |
| Q33787452 | A network-based biomarker approach for molecular investigation and diagnosis of lung cancer |
| Q36109706 | A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients |
| Q28602622 | A network-based method to evaluate quality of reproducibility of differential expression in cancer genomics studies |
| Q50605014 | A novel algorithm for network-based prediction of cancer recurrence |
| Q37220763 | A novel bi-level meta-analysis approach: applied to biological pathway analysis |
| Q53420712 | A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity. |
| Q38021583 | A quick guide to biomolecular network studies: Construction, analysis, applications, and resources |
| Q33407784 | A statistical framework for integrating two microarray data sets in differential expression analysis |
| Q33483366 | A systems biology-based gene expression classifier of glioblastoma predicts survival with solid tumors |
| Q30974030 | Accurate and reliable cancer classification based on probabilistic inference of pathway activity |
| Q34277314 | Algebraic Comparison of Partial Lists in Bioinformatics |
| Q42927159 | Algorithms for Discovery of Multiple Markov Boundaries. |
| Q40507988 | An Application of Sequential Meta-Analysis to Gene Expression Studies |
| Q37550211 | An integrated systems genetics screen reveals the transcriptional structure of inherited predisposition to metastatic disease |
| Q33587458 | Analysis and computational dissection of molecular signature multiplicity |
| Q47976347 | Analysis of blood-based gene expression in idiopathic Parkinson disease |
| Q40120107 | Application of toxicogenomics to genetic toxicology risk assessment |
| Q84516567 | Are expression profiles meaningless for cancer studies? |
| Q39734181 | Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials |
| Q33287498 | Autocorrelation analysis reveals widespread spatial biases in microarray experiments |
| Q39138880 | Balancing the robustness and predictive performance of biomarkers. |
| Q34360830 | Batch effect removal methods for microarray gene expression data integration: a survey |
| Q33531526 | Bimodal gene expression patterns in breast cancer |
| Q33410835 | Biological convergence of cancer signatures |
| Q30356765 | Biologically inspired intelligent decision making: a commentary on the use of artificial neural networks in bioinformatics |
| Q42467730 | Breast cancer molecular profiling with single sample predictors: a retrospective analysis |
| Q30832440 | Breast cancer prognosis risk estimation using integrated gene expression and clinical data |
| Q47633149 | Building Diversified Multiple Trees for classification in high dimensional noisy biomedical data. |
| Q33323244 | Can subtle changes in gene expression be consistently detected with different microarray platforms? |
| Q33511962 | Can survival prediction be improved by merging gene expression data sets? |
| Q55049733 | Cancer growth and metastasis as a metaphor of Go gaming: An Ising model approach. |
| Q35124393 | Cancer-risk module identification and module-based disease risk evaluation: a case study on lung cancer |
| Q40887366 | Causal Genetic Inference Using Haplotypes as Instrumental Variables |
| Q57191819 | Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders |
| Q37366183 | Chipping away at diagnostics for neurodegenerative diseases |
| Q38099764 | Chromosomal instability and transcriptome dynamics in cancer |
| Q33521384 | Classification across gene expression microarray studies |
| Q47102166 | Classification of gene signatures for their information value and functional redundancy |
| Q38973304 | Clonal evolution of colorectal cancer in IBD. |
| Q33375877 | Comparative optimism in models involving both classical clinical and gene expression information. |
| Q34330032 | Comparison of different normalization assumptions for analyses of DNA methylation data from the cancer genome |
| Q51551195 | Comparison of toxicity and transcriptomic profiles in a diatom exposed to oil, dispersants, dispersed oil |
| Q34725022 | Comprehensive human urine standards for comparability and standardization in clinical proteome analysis |
| Q46577019 | Computational purification of tumor gene expression data |
| Q36321061 | Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson's disease: a comparison of 33 human and animal studies. |
| Q37756398 | Correlation between gene expression profiling-based molecular and morphologic classification of breast cancer |
| Q37132723 | Correlation signature of the macroscopic states of the gene regulatory network in cancer |
| Q30790283 | Covariance adjustment for batch effect in gene expression data |
| Q40646057 | Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer |
| Q33351080 | Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study |
| Q31113844 | Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes |
| Q33992544 | Current and future use of genomics data in toxicology: Opportunities and challenges for regulatory applications |
| Q35082280 | Current composite-feature classification methods do not outperform simple single-genes classifiers in breast cancer prognosis. |
| Q31087381 | Data Requirements for Model-Based Cancer Prognosis Prediction |
| Q36083333 | Dealing with prognostic signature instability: a strategy illustrated for cardiovascular events in patients with end-stage renal disease |
| Q30792298 | Deciphering global signal features of high-throughput array data from cancers |
| Q33748879 | Derivation of Cancer Diagnostic and Prognostic Signatures from Gene Expression Data |
| Q30479535 | Detecting multivariate differentially expressed genes |
| Q93050593 | Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia |
| Q35197454 | Development and validation of a quantitative real-time polymerase chain reaction classifier for lung cancer prognosis. |
| Q34147751 | Differential gene expression in primary breast tumors associated with lymph node metastasis |
| Q30558563 | Direct integration of intensity-level data from Affymetrix and Illumina microarrays improves statistical power for robust reanalysis |
| Q34360177 | Discovery and validation of gene classifiers for endocrine-disrupting chemicals in zebrafish (danio rerio). |
| Q37656262 | Discovery of prostate cancer biomarkers by microarray gene expression profiling |
| Q55514141 | Discriminating early- and late-stage cancers using multiple kernel learning on gene sets. |
| Q37508134 | Discriminating gene expression signature of radiation-induced thyroid tumors after either external exposure or internal contamination. |
| Q35538892 | Distance-based classifiers as potential diagnostic and prediction tools for human diseases |
| Q42459356 | Distribution of molecular breast cancer subtypes in middle eastern-saudi arabian women: a pilot study |
| Q33851661 | Do two machine-learning based prognostic signatures for breast cancer capture the same biological processes? |
| Q33413444 | Does the biomarker search paradigm need re-booting? |
| Q61805560 | EMT network-based feature selection improves prognosis prediction in lung adenocarcinoma |
| Q34189368 | Effect of size and heterogeneity of samples on biomarker discovery: synthetic and real data assessment |
| Q36728943 | Effective use of microarrays in neuroendocrine research |
| Q34766433 | Effects of sample size on differential gene expression, rank order and prediction accuracy of a gene signature |
| Q37209400 | Effects of sample size on robustness and prediction accuracy of a prognostic gene signature |
| Q37127240 | Enabling personalized cancer medicine through analysis of gene-expression patterns |
| Q37689484 | Ensemble inference by integrative cancer networks |
| Q34977707 | Estimating relative noise to signal in DNA microarray data |
| Q34131312 | Evaluating reproducibility of differential expression discoveries in microarray studies by considering correlated molecular changes |
| Q36026699 | Evaluation of drug-targetable genes by defining modes of abnormality in gene expression. |
| Q34020695 | Expectations, validity, and reality in gene expression profiling |
| Q30536424 | Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies |
| Q37809870 | Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities |
| Q80217907 | Expression signatures that correlated with Gleason score and relapse in prostate cancer |
| Q43580446 | Extensive increase of microarray signals in cancers calls for novel normalization assumptions |
| Q34123325 | Extensive up-regulation of gene expression in cancer: the normalised use of microarray data |
| Q50960359 | Extracting a few functionally reproducible biomarkers to build robust subnetwork-based classifiers for the diagnosis of cancer |
| Q33418596 | Factors influencing the statistical power of complex data analysis protocols for molecular signature development from microarray data |
| Q34592372 | Feature selection and classifier performance on diverse bio- logical datasets |
| Q37992853 | Finding biomarkers is getting easier |
| Q37802908 | From genomic landscapes to personalized cancer management—is there a roadmap? |
| Q33579381 | From the bench to the clinic and back again: translational biomarker discovery using in silico mining of pharmacogenomic data |
| Q34218803 | Functional Genomics and a New Era in Radiation Biology and Oncology |
| Q30496004 | Functional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes |
| Q33962784 | Functional characterization of breast cancer using pathway profiles |
| Q37038698 | Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer |
| Q39638989 | Functional roles for redox genes in ethanol sensitivity in Drosophila |
| Q34704073 | GOBO: gene expression-based outcome for breast cancer online |
| Q42601902 | Gene Pathway Analysis of Hepatocellular Carcinoma Genomic Expression Datasets |
| Q79184252 | Gene expression profiling for individualized breast cancer chemotherapy: success or not? |
| Q30851418 | Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers |
| Q35228753 | Gene expression profiling in human lung development: an abundant resource for lung adenocarcinoma prognosis. |
| Q38034387 | Gene expression profiling in human neurodegenerative disease |
| Q33920272 | Gene set analysis methods: statistical models and methodological differences |
| Q38717253 | Gene-expression signatures in ovarian cancer: Promise and challenges for patient stratification. |
| Q35996412 | Gene-set activity toolbox (GAT): A platform for microarray-based cancer diagnosis using an integrative gene-set analysis approach |
| Q37089701 | Gene-set analysis and reduction |
| Q35933373 | Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients. |
| Q37523207 | Genetic prognostic and predictive markers in colorectal cancer |
| Q48674329 | Genome-wide expression profiling as a clinical tool: are we there yet? |
| Q57286593 | Genome-wide expression profiling of glioblastoma using a large combined cohort |
| Q44958045 | Genomic predictors of prostate cancer therapy outcomes |
| Q38835169 | Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning |
| Q36844700 | Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research |
| Q60046635 | GradientScanSurv-An exhaustive association test method for gene expression data with censored survival outcome |
| Q94566562 | Hepatic molecular signatures highlight the sexual dimorphism of Non-Alcoholic SteatoHepatitis (NASH) |
| Q34206403 | High accordance in prognosis prediction of colorectal cancer across independent datasets by multi-gene module expression profiles |
| Q37975999 | How advancement in biological network analysis methods empowers proteomics |
| Q31126623 | INDEED: Integrated differential expression and differential network analysis of omic data for biomarker discovery |
| Q64981125 | INDEED: R package for network based differential expression analysis. |
| Q41557019 | Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm |
| Q37347804 | Identification of breast cancer patients based on human signaling network motifs |
| Q37214325 | Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers |
| Q92217550 | Identification of the gene signature reflecting schizophrenia's etiology by constructing artificial intelligence-based method of enhanced reproducibility |
| Q39783129 | Identifying Prognostic SNPs in Clinical Cohorts: Complementing Univariate Analyses by Resampling and Multivariable Modeling |
| Q36367090 | Identifying biologically relevant putative mechanisms in a given phenotype comparison |
| Q55475012 | Identifying differentially expressed genes from cross-site integrated data based on relative expression orderings. |
| Q33683844 | Identifying disease-associated pathways in one-phenotype data based on reversal gene expression orderings |
| Q36559266 | Identifying protein interaction subnetworks by a bagging Markov random field-based method. |
| Q36762532 | Idiotypic networks: toward a renaissance? |
| Q30242020 | Imaging biomarker roadmap for cancer studies |
| Q30587110 | Impact of Experimental Noise and Annotation Imprecision on Data Quality in Microarray Experiments |
| Q36277294 | Incorporating prior biological knowledge for network-based differential gene expression analysis using differentially weighted graphical LASSO. |
| Q37356830 | Incorporating topological information for predicting robust cancer subnetwork markers in human protein-protein interaction network |
| Q36117179 | Independent and functional validation of a multi-tumour-type proliferation signature |
| Q34110415 | Inferring cancer subnetwork markers using density-constrained biclustering |
| Q42638788 | Integrated analysis of numerous heterogeneous gene expression profiles for detecting robust disease-specific biomarkers and proposing drug targets |
| Q35779338 | Integrated cross-species transcriptional network analysis of metastatic susceptibility |
| Q45943258 | Integrating Clinical and Multiple Omics Data for Prognostic Assessment across Human Cancers. |
| Q36254933 | Integrating gene set analysis and nonlinear predictive modeling of disease phenotypes using a Bayesian multitask formulation. |
| Q33719052 | Integration of biological knowledge and gene expression data for biomarker selection: FN1 as a potential predictor of radiation resistance in head and neck cancer |
| Q48198752 | Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratification of cancer patients |
| Q60946450 | Integrative Analysis of Global Gene Expression Identifies Opposite Patterns of Reactive Astrogliosis in Aged Human Prefrontal Cortex |
| Q91746560 | Integrative Gene Selection on Gene Expression Data: Providing Biological Context to Traditional Approaches |
| Q35177024 | Integrative analysis of survival-associated gene sets in breast cancer |
| Q28744621 | Integrative computational biology for cancer research |
| Q31160607 | Interpretation of genomic data: questions and answers |
| Q33417129 | Investigation of reproducibility of differentially expressed genes in DNA microarrays through statistical simulation |
| Q39955702 | Is there a niche for DNA microarrays in molecular diagnostics? |
| Q37106813 | Lost in translation: problems and pitfalls in translating laboratory observations to clinical utility |
| Q37708137 | Lung cancer progression and metastasis from the prognostic point of view. |
| Q35143671 | Machine learning applications in cancer prognosis and prediction |
| Q45997545 | Making connections: using networks to stratify human tumors. |
| Q36883920 | Markov Boundary Discovery with Ridge Regularized Linear Models |
| Q37024519 | Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer |
| Q36343603 | Meta-analysis approach as a gene selection method in class prediction: does it improve model performance? A case study in acute myeloid leukemia |
| Q31110581 | Meta-analysis of gene expression data: a predictor-based approach |
| Q31171330 | Meta-analysis of microarray studies reveals a novel hematopoietic progenitor cell signature and demonstrates feasibility of inter-platform data integration |
| Q64890641 | MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature. |
| Q30066455 | Metabolomics in the study of kidney diseases |
| Q34820314 | Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement |
| Q37356684 | Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet? |
| Q30588294 | Molecular Signature of Cancer at Gene Level or Pathway Level? Case Studies of Colorectal Cancer and Prostate Cancer Microarray Data |
| Q37974614 | Molecular classification of breast carcinomas with particular emphasis on “basal‐like” carcinoma: A critical review |
| Q37444718 | Molecular classification of solid tumours: towards pathway-driven therapeutics |
| Q33759568 | Multi-factorial analysis of class prediction error: estimating optimal number of biomarkers for various classification rules |
| Q33741210 | Multi-level reproducibility of signature hubs in human interactome for breast cancer metastasis |
| Q38923591 | Multi-omic approaches for characterization of hepatocellular carcinoma |
| Q92880415 | Multigene signatures of responses to chemotherapy derived by biochemically-inspired machine learning |
| Q35671355 | Multiple signatures of a disease in potential biomarker space: Getting the signatures consensus and identification of novel biomarkers |
| Q34478588 | NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics Signatures |
| Q89944347 | Network Properties of Cancer Prognostic Gene Signatures in the Human Protein Interactome |
| Q38483765 | Network cluster analysis of protein-protein interaction network identified biomarker for early onset colorectal cancer |
| Q42681658 | Network information improves cancer outcome prediction |
| Q34998178 | Network signatures of survival in glioblastoma multiforme |
| Q90439227 | Network-Based Approaches for Pathway Level Analysis |
| Q31140600 | Network-Based Biomedical Data Analysis |
| Q29616384 | Network-based classification of breast cancer metastasis |
| Q33407778 | Network-based support vector machine for classification of microarray samples |
| Q43958226 | Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis |
| Q30486130 | On reliable discovery of molecular signatures |
| Q40234104 | On the Sample Complexity of Cancer Pathways Identification. |
| Q39146393 | Opportunities and Challenges of Multiplex Assays: A Machine Learning Perspective |
| Q42762256 | Optimally discriminative subnetwork markers predict response to chemotherapy |
| Q33406663 | Outcome prediction based on microarray analysis: a critical perspective on methods |
| Q31114014 | Overcoming the matched-sample bottleneck: an orthogonal approach to integrate omic data |
| Q28732256 | Parallel Evolution under Chemotherapy Pressure in 29 Breast Cancer Cell Lines Results in Dissimilar Mechanisms of Resistance |
| Q33347604 | Pathway analysis reveals functional convergence of gene expression profiles in breast cancer |
| Q26995884 | Pathway mapping and development of disease-specific biomarkers: protein-based network biomarkers |
| Q26852625 | Pattern recognition in bioinformatics |
| Q36158678 | Pharmacogenomics of platinum-based chemotherapy in NSCLC |
| Q47771226 | PhenoNet: identification of key networks associated with disease phenotype |
| Q28741720 | Post-genomic clinical trials: the perspective of ACGT |
| Q61804782 | Predict drug sensitivity of cancer cells with pathway activity inference |
| Q34137110 | Predicting Antitumor Activity of Peptides by Consensus of Regression Models Trained on a Small Data Sample |
| Q35075520 | Predicting interpretability of metabolome models based on behavior, putative identity, and biological relevance of explanatory signals |
| Q36014711 | Predicting outcomes in radiation oncology--multifactorial decision support systems |
| Q34148173 | Predicting relapse prior to transplantation in chronic myeloid leukemia by integrating expert knowledge and expression data |
| Q36117673 | Prediction and prognosis: impact of gene expression profiling in personalized treatment of breast cancer patients |
| Q37279681 | Prediction of breast cancer metastasis by genomic profiling: where do we stand? |
| Q39998940 | Prediction of cancer outcome using DNA microarray technology: past, present and future. |
| Q35024682 | Prediction of individual response to anticancer therapy: historical and future perspectives |
| Q21183974 | Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets |
| Q33328961 | Predictive gene lists for breast cancer prognosis: a topographic visualisation study |
| Q31148892 | Preprocessing, classification modeling and feature selection using flow injection electrospray mass spectrometry metabolite fingerprint data |
| Q37457708 | Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways. |
| Q33361596 | Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets |
| Q30485836 | Prognostic gene signatures for non-small-cell lung cancer |
| Q36021090 | Prognostic value of a 92-probe signature in breast cancer |
| Q35022194 | Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the Eur |
| Q34042616 | Protein networks as logic functions in development and cancer |
| Q42704059 | Protein subnetwork markers improve prediction of cancer outcome |
| Q36973777 | Proteome-based diagnostics and prognosis of bladder transitional cell carcinoma |
| Q37636447 | Proteomic Workflows for Biomarker Identification Using Mass Spectrometry - Technical and Statistical Considerations during Initial Discovery |
| Q31034756 | Quantifying stability in gene list ranking across microarray derived clinical biomarkers |
| Q33518038 | Quantitative comparison of microarray experiments with published leukemia related gene expression signatures |
| Q38427565 | Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays. |
| Q37831322 | Quantitative knowledge-based analysis in compound safety assessment |
| Q45235399 | R2KS: A Novel Measure for Comparing Gene Expression Based on Ranked Gene Lists |
| Q64111712 | Radiomics and Machine Learning for Radiotherapy in Head and Neck Cancers |
| Q34123835 | Reproducibility and concordance of differential DNA methylation and gene expression in cancer |
| Q35533812 | Reproducibility enhancement and differential expression of non predefined functional gene sets in human genome |
| Q34056239 | Reproducible Cancer Biomarker Discovery in SELDI-TOF MS Using Different Pre-Processing Algorithms |
| Q33644852 | Robust Prediction of t-Year Survival with Data from Multiple Studies |
| Q33742148 | Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease |
| Q33683937 | Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms |
| Q34363908 | Sample size planning for survival prediction with focus on high-dimensional data |
| Q36519219 | Selecting cases for whom additional tests can improve prognostication. |
| Q33254835 | Selecting normalization genes for small diagnostic microarrays |
| Q35411665 | Semi-supervised learning improves gene expression-based prediction of cancer recurrence |
| Q34056629 | Stability investigations of multivariable regression models derived from low- and high-dimensional data |
| Q33960208 | Stability of ranked gene lists in large microarray analysis studies |
| Q33839153 | Stable Gene Selection from Microarray Data via Sample Weighting |
| Q35785820 | Subtype prediction in pediatric acute myeloid leukemia: classification using differential network rank conservation revisited |
| Q34104071 | Survival models with preclustered gene groups as covariates |
| Q42585784 | Survival prediction of stage I lung adenocarcinomas by expression of 10 genes |
| Q38264304 | Systems biology meets -omic technologies: novel approaches to biomarker discovery and companion diagnostic development. |
| Q57716604 | Systems biology: opening new avenues in clinical research |
| Q34402910 | Systems vaccinology |
| Q35784377 | Systems vaccinology: learning to compute the behavior of vaccine induced immunity |
| Q62669975 | Systems-based biological concordance and predictive reproducibility of gene set discovery methods in cardiovascular disease |
| Q44826618 | Tailoring sparse multivariable regression techniques for prognostic single‐nucleotide polymorphism signatures |
| Q30854540 | Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data |
| Q24597089 | The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements |
| Q30512428 | The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models |
| Q37013893 | The RNA continent |
| Q38869523 | The Utility of Multiplex Assays for Identification of Proteomic Signatures in Psychiatry |
| Q35085317 | The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence |
| Q33369599 | The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies |
| Q33845381 | The impact of quantitative optimization of hybridization conditions on gene expression analysis |
| Q34113527 | The influence of feature selection methods on accuracy, stability and interpretability of molecular signatures |
| Q37036319 | The origins of breast cancer prognostic gene expression profiles |
| Q37962377 | The present and future of gene profiling in breast cancer. |
| Q36857285 | The prognostic landscape of genes and infiltrating immune cells across human cancers |
| Q35667675 | The role of gene expression profiling in early-stage non-small cell lung cancer |
| Q92594063 | Topologically inferring active miRNA-mediated subpathways toward precise cancer classification by directed random walk |
| Q30988064 | Topologically inferring pathway activity toward precise cancer classification via integrating genomic and metabolomic data: prostate cancer as a case |
| Q45171649 | Topologically inferring risk-active pathways toward precise cancer classification by directed random walk |
| Q38300326 | Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244) |
| Q38079125 | Translating metastasis-related biomarkers to the clinic--progress and pitfalls |
| Q37123504 | Translational microarray systems for outcome prediction of hepatocellular carcinoma |
| Q34000961 | Translational research in head and neck cancer. Biological characteristics and general aspects |
| Q34207522 | Use of gene expression data for predicting continuous phenotypes for animal production and breeding. |
| Q36382520 | Using activation status of signaling pathways as mechanism-based biomarkers to predict drug sensitivity |
| Q33397732 | Using pathway signatures as means of identifying similarities among microarray experiments |
| Q33548788 | Using pre-existing microarray datasets to increase experimental power: application to insulin resistance |
| Q41843888 | Using protein interaction database and support vector machines to improve gene signatures for prediction of breast cancer recurrence |
| Q36743357 | Using the information embedded in the testing sample to break the limits caused by the small sample size in microarray-based classification |
| Q34306646 | Volcano plots in analyzing differential expressions with mRNA microarrays. |
| Q38089853 | What does systems biology mean for biomarker discovery? |
| Q34619146 | Why is it so difficult to data mine relevant genome-scale biomarkers? |
| Q35863651 | iRDA: a new filter towards predictive, stable, and enriched candidate genes |
| Q38192078 | miRNA as markers for the diagnostic screening of colon cancer |
| Q37213260 | omniBiomarker: A Web-Based Application for Knowledge-Driven Biomarker Identification |
| Q31127033 | t-Test at the Probe Level: An Alternative Method to Identify Statistically Significant Genes for Microarray Data |
Search more.